Code: MTA9183 | Publication Date: Sep 2025 |
The market is growing quickly as treatment methodologies are being pushed, the incidence of neurological disorders rises, the number of physiotherapy treatments increases, and the number of drug therapies increases daily. The increasing awareness level and ongoing rehabilitation programs support the positive growth of the spasticity market.
The trends of the Spasticity Market show increased adoption of a multi-modal approach that depends on medication, physical therapy, and surgery. The rise of intrathecal baclofen therapy and botulinum toxin injections is on the rise, indicating better functionality and quality of life for patients.
Lastly, another trend in the Spasticity Market is the acceptance of digital health solutions used to monitor the patient's journey and delivery of care. The use of artificial intelligence-directed rehabilitation tools, telehealth treatment and assessment sessions, and wearable technology continues to expand access and develop tailored interventions.
The Spasticity Market developments are centered on research in novel therapeutics, including gene therapy and regenerative medicine, aimed at targeting the root causes of spasticity. Such innovations are gaining momentum as clinical trials progress, offering promising long-term treatment pathways.
Additionally, the Spasticity Market is experiencing developments in surgical techniques, such as selective dorsal rhizotomy, alongside innovations in robotic-assisted rehabilitation devices. Pharmaceutical companies are expanding their portfolios with extended-release formulations and combination therapies to address unmet medical needs.
Some of the leading companies include: